Hereditary Antithrombin Deficiency — Results of a Family Study

  • B. Maak
  • S. Hutschenreiter
  • F. H. Herrmann
  • K. Wulff
  • A. Siegemund
  • W. Christoph
Conference paper


Venous thrombosis or thromboembolism in younger people and especially in children or adolescents is in the majority of cases related to one or more inherited defects of naturally occurring antithrombotic proteins.


Anticardiolipin Antibody Antithrombin Activity Antithrombin Deficiency Factor Versus Gene Venous Thromboembolic Complication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, De Sai D, Grant R, Israels S, Jardine L, Luke B, Masciotte P, Silva M (1994). Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83: 1251–1257PubMedGoogle Scholar
  2. 2.
    Dahlbäck B, Carlsson M, Svensson P J (1993). Familial thrombophilia du to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nail Acad Sci USA 90: 1004–1008CrossRefGoogle Scholar
  3. 3.
    Demers C, Ginsberg J S, Hirsh J, Henderson P, Blajchman M A (1992). Thrombosis in antithrombin-III-deficient persons. Ann Int Med 116: 754–761PubMedGoogle Scholar
  4. 4.
    Egeberg 0 (1965). Inherited antithrombin deficiency causing thrombophilia. Thromb Diath haemorrh 13: 516–530PubMedGoogle Scholar
  5. 5.
    Halbmayer W M, Mannhalter C, Feichtinger C, Rubi K, Fischer M (1992). The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and or arterial thromboembolism. Thromb Haemostas 68: 285–290Google Scholar
  6. 6.
    Herrmann F H, Koesling M, Schröder W, Altman R, Jimenez Bonilla R, Lopaciuk S, PerezRequejo J L, Singh J R (1997). Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 14: 403–411PubMedCrossRefGoogle Scholar
  7. 7.
    Hirsh J, Piovella F, Pini M (1989). Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med 87 (suppl. 3 B): 34S-38CrossRefGoogle Scholar
  8. 8.
    Lane D A, Olds R R, Thein S L (1992). Antithrombin and its deficiency states. Blood Coagul Fibrinolys 3: 315–341CrossRefGoogle Scholar
  9. 9.
    Levi M, Hack C E, de Boer J P, Brandjes D P M, Buller H R, ten Cate J W (1991). Reduction of contact activation relation related fibrinolytic activity in factor XII deficient patients. J clin Invest 88: 1155–1160PubMedCrossRefGoogle Scholar
  10. 10.
    Mackie M, Bennett B, Ogston D, Douglas A S (1978). Familial thrombosis: inherited deficiency of antithrombin III. Brit Med J 1: 136–138PubMedCrossRefGoogle Scholar
  11. 11.
    Mannhalter C, Fischer M, Hopmeier P, Deutsch E (1987). Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. Fibrinolysis 1: 259–263CrossRefGoogle Scholar
  12. 12.
    Mitchell L, Piovella F, Ofosu F, Andrew M (1991). a-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 78: 2299–2304PubMedGoogle Scholar
  13. 13.
    Rees D C, Cox M, Clegg J B (1995). World distribution of factor V Leiden. Lancet 346: 1133–1134PubMedCrossRefGoogle Scholar
  14. 14.
    de Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiro F, Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci P M (1994). Clinical manifestations and management of inherited thrombophilia• retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thrombos Haemostas 72: 352–358Google Scholar
  15. 15.
    Taisuke K, Takashi 0, Koichi 0, Mika K, Kazuya S, Naotaka H, Yoshiyuki N (1998). A common genetic polymorphism (46 C to T substitution) in the 5’-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 91: 2010–2014Google Scholar
  16. 16.
    Wells P S, Blajchman M A, Henderson P, Wells M J, Demers C, Bourque R, Mc Avoy A (1994). Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study. Am J Hematol 45: 321–324PubMedCrossRefGoogle Scholar
  17. 17.
    Winter M, Gallimore M, Jones D W (1995). Should factor XII assays be included in thrombophilia screening? Lancet 346: 52PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • B. Maak
  • S. Hutschenreiter
  • F. H. Herrmann
  • K. Wulff
  • A. Siegemund
  • W. Christoph

There are no affiliations available

Personalised recommendations